03-Nov-15 Chinese diabetes tech firm Sinocare has signed an agreement to acquire Nipro Diagnostics from Japan's Nipro Corp, for USD273 mn. Nipro Diagnostics is based in Florida and manufacturers products for people with diabetes, including a portfolio of blood glucose monitoring technologies. Sinocare CEO Shaobo Li said “Diabetes has become one of the biggest challenges to our public healthcare system and society." [image: Sinocare]

30-Oct-15 Hanoi’s health sector has focused on developing high-quality medical techniques over the last five years. Saint Paul, a leading hospital in the city, has earmarked funding for modern equipment and advanced technologies, focusing on thoracic endoscopic surgery, treatment of digestive and urologic diseases, brain tumor surgery and analgesic treatments for cancer patients. [image: VNA]

29-Oct-15 China's healthcare products exports have increased by 18% a year since 2008, reaching nearly USD13 bn in 2014. Medical device exporters - including Microport, Mindray, Kanghui, Wego and Andon - are not only targeting Western countries but emerging markets as well. Chinese brands are perceived as competitive on price and quality, but viewed less favorably on value and reliability. [image: Reuters]

15-Oct-15 Vetter, a global leader in aseptic manufacturing of drug-delivery systems, has announced a new business entity in Japan. As the second largest pharmaceutical single market, Japan is home to a number of leading global companies which offer a promising injectable pipeline. [image: Business Wire]

30-Sep-15 Experts in China are urging more intensive management of hypertension in the nation, where 330 million people are affected by the illness. As in the US, guidelines in China recommend a maximum systolic pressure of 140. But a maximum of 120 could help save lives of over 50s with at least one additional risk factor, a US study has found. [image: China Daily]